Michael Gelband’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-65,011
Closed -$19.1M 1651
2024
Q3
$19.1M Buy
65,011
+35,291
+119% +$9.95M 0.12% 144
2024
Q2
$7.21M Buy
+29,720
New +$7.09M 0.05% 314
2022
Q3
Sell
-10,693
Closed -$1.95M 1983
2022
Q2
$1.95M Buy
10,693
+985
+10% +$197K 0.02% 788
2022
Q1
$2.3M Buy
+9,708
New +$2.29M 0.03% 712
2021
Q4
Sell
-24,698
Closed -$6.26M 2265
2021
Q3
$6.26M Buy
24,698
+21,856
+769% +$5.68M 0.08% 322
2021
Q2
$681K Buy
+2,842
New +$635K 0.01% 1204
2020
Q4
Sell
-34,785
Closed -$5.46M 2055
2020
Q3
$5.46M Buy
+34,785
New +$5.7M 0.11% 162

Other funds holding EFX

Michael Gelband's EFX Position: Q4 2024 in Review

Michael Gelband sold out of Equifax (EFX) in Q4 2024, closing a stake of 65,011 shares — an estimated $19.1M sold.

Michael Gelband first reported a position in EFX in Q3 2020 and held it in 7 quarters. The position peaked at $19.1M in Q3 2024. 849 funds tracked by Wall St. Rank hold EFX as of Q4 2024.

  • Michael Gelband reported no remaining Equifax position as of Q4 2024 after selling out during the quarter.
  • Michael Gelband sold 65,011 Equifax shares in Q4 2024, an estimated $19.1M.
  • Michael Gelband first reported a position in Equifax in Q3 2020 and held it in 7 quarters.
  • Michael Gelband's Equifax position peaked at $19.1M in Q3 2024.
  • 849 funds tracked by Wall St. Rank held Equifax as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.